Caitlin Raymond/LinkedIn
Jan 13, 2026, 16:38
Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared on LinkedIn:
”New post, inspired by a case I saw on service: TTP’s Little-Known Cousin: Understanding TAMOF as a TTP-Like Process.
TAMOF is often mislabeled as DIC or dismissed as “just sepsis.”
But mechanistically, it behaves like a secondary thrombotic microangiopathy — driven by endothelial activation, ultra-large vWF, and insufficient ADAMTS13 in context.
The labs are subtle:
- Low platelets
- High LDH
- ± MAHA
- Relatively preserved coagulation studies
Seeing the pattern matters, because TAMOF may be treatable, including consideration of plasma exchange.”
Read the full post here.
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 18:12Adil Nawaz: Extended Dual Antiplatelet Therapy After Coronary Stenting
-
Oct 16, 2026, 17:50Elad Asher։ STORM-PE Shows Functional Benefits of Thrombectomy
-
Oct 16, 2026, 17:32Shruthi Narayan: STORM-PE and STRIKE-PE Studies Advance Understanding of Recovery After Pulmonary Embolism
-
Oct 16, 2026, 17:22Wolfgang Miesbach։ What a Near-Perfect FISH Score Fails to See
-
Oct 16, 2026, 17:06Troels Wienecke: Connecting Myeloproliferative Disease and Ischemic Stroke
-
Oct 16, 2026, 17:03Only 5 Days Left to Submit Your Research for EAHAD 2027
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand